keyword
MENU ▼
Read by QxMD icon Read
search

Burning mouth syndrome

keyword
https://www.readbyqxmd.com/read/28210449/oral-mucosal-lesions-in-a-chilean-elderly-population-a-retrospective-study-with-a-systematic-review-from-thirteen-countries
#1
César Rivera, Daniel Droguett, María-Jesús Arenas-Márquez
BACKGROUND: The oral examination is an essential part of the multidisciplinary medical care in elderly people. Oral mucosal lesions and normal variations of oral anatomy (OMLs) are very common in this people, but few studies have examined the frequency and prevalence of these conditions worldwide and less in Chile. The aim of this research was to evaluate the frequency of OMLs in a Chilean elderly population. MATERIAL AND METHODS: It was conducted a retrospective study (Talca, Chile)...
February 2017: Journal of Clinical and Experimental Dentistry
https://www.readbyqxmd.com/read/28199919/relationships-between-oral-muc1-expression-and-salivary-hormones-in-burning-mouth-syndrome
#2
Jeong-Hyun Kang, Yoon-Young Kim, Ji-Youn Chang, Hong-Seop Kho
OBJECTIVES: To investigate possible relationships among oral mucosal epithelial MUC1 expression, salivary female gonadal hormones and stress markers, and clinical characteristics in patients with burning mouth syndrome (BMS). DESIGN: Thirty post-menopausal female patients with BMS (60.0±5.0 years) were included. Clinical and psychological evaluations were performed and the expression level of oral mucosal epithelial MUC1 was analyzed. The levels of cortisol, dehydroepiandrosterone (DHEA), 17β-estradiol, progesterone, chromogranin A, and blood contamination were determined from unstimulated whole saliva (UWS) and stimulated whole saliva (SWS) samples...
February 4, 2017: Archives of Oral Biology
https://www.readbyqxmd.com/read/28197700/-the-alpha-herpesviridae-in-dermatology-varicella-zoster-virus-german-version
#3
REVIEW
L El Hayderi, A Rübben, A F Nikkels
The second part of this publication deals with varicella zoster virus (VZV) and presents an overview of new, rare, and atypical clinical manifestations, including photolocalized varicella, hemorrhagic bullae during varicella, the implication of VZV in immunoglobulin A vasculitis, VZV-related alopecia, ulcerative varicella skin lesions, childhood herpes zoster (HZ), prolonged prodromal pains, recurrent HZ, VZV implication in burning mouth syndrome, verruciform VZV lesions, the significance of satellite lesions during HZ, and late HZ complications, either neurological or internal...
February 14, 2017: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/28197699/-the-alpha-herpesviridae-in-dermatology-herpes-simplex-virus-types%C3%A2-i-and-ii-german-version
#4
REVIEW
L El Hayderi, A Rübben, A F Nikkels
This review on herpes simplex virus type I and type II (HSV-I, HSV-II) summarizes recent developments in clinical manifestations and treatment interventions for primary and recurrent orolabial and genital herpes, as well as those regarding vaccination issues. Among the clinical presentations, the relationship between pyogenic granuloma and chronic HSV-I infection; HSV-related folliculitis; verrucous HSV-I and HSV-II lesions; the role of recurrent HSV-I infection in burning mouth syndrome; HSV-I and HSV-II infection of the periareolar area; zosteriform HSV; the "knife-cut sign"; and the preferential colonization and infection of preexisting dermatoses by HSV-I or HSV-II are discussed...
February 14, 2017: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/28197698/the-alpha-herpesviridae-in-dermatology-herpes-simplex-virus-types%C3%A2-i-and-ii
#5
REVIEW
L El Hayderi, A Rübben, A F Nikkels
This review on herpes simplex virus type I and type II (HSV‑I, HSV‑II) summarizes recent developments in clinical manifestations and treatment interventions for primary and recurrent orolabial and genital herpes, as well as those regarding vaccination issues. Among the clinical presentations, the relationship between pyogenic granuloma and chronic HSV‑I infection; HSV-related folliculitis; verrucous HSV‑I and HSV‑II lesions; the role of recurrent HSV‑I infection in burning mouth syndrome; HSV‑I and HSV‑II infection of the periareolar area; zosteriform HSV; the "knife-cut sign"; and the preferential colonization and infection of preexisting dermatoses by HSV‑I or HSV‑II are discussed...
February 14, 2017: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/28197697/the-alpha-herpesviridae-in-dermatology-varicella-zoster-virus
#6
REVIEW
L El Hayderi, A Rübben, A F Nikkels
The second part of this publication deals with varicella zoster virus (VZV) and presents an overview of new, rare, and atypical clinical manifestations, including photolocalized varicella, hemorrhagic bullae during varicella, the implication of VZV in immunoglobulin A vasculitis, VZV-related alopecia, ulcerative varicella skin lesions, childhood herpes zoster (HZ), prolonged prodromal pains, recurrent HZ, VZV implication in burning mouth syndrome, verruciform VZV lesions, the significance of satellite lesions during HZ, and late HZ complications, either neurological or internal...
February 14, 2017: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete
https://www.readbyqxmd.com/read/28142210/geriatric-oral-and-maxillofacial-dysfunctions-in-the-context-of-geriatric-syndrome
#7
REVIEW
Yoon Nam, Nam-Hee Kim, Hong-Seop Kho
OBJECTIVES: To propose the application of the concept of geriatric syndrome for common geriatric oral and maxillofacial dysfunctions and to suggest the necessity of developing effective evaluation methods for oral and maxillofacial frailty. DESIGN: The concepts of frailty and geriatric syndrome based on multi-morbidity and polypharmacy were applied to five common geriatric oral medicinal dysfunctional problems: salivary gland hypofunction (dry mouth), chronic oral mucosal pain disorders (burning mouth symptoms), taste disorders (taste disturbances), swallowing disorders (dysphagia), and oral and maxillofacial movement disorders (oromandibular dyskinesia and dystonia)...
January 31, 2017: Oral Diseases
https://www.readbyqxmd.com/read/28112423/comparison-of-salivary-cortisol-and-%C3%AE-amylase-levels-and-psychological-profiles-in-patients-with-burning-mouth-syndrome
#8
Tahereh Nosratzehi, Saeedeh Salimi, Azadeh Parvaee
PURPOSE: The aim of the study was to compare salivary cortisol and α-amylase levels and psychological profiles in patients with burning mouth syndrome (BMS) and healthy subjects. METHODS AND MATERIALS: Spitting method was used to collect unstimulated salivary. Salivary cortisol and α-amylase levels were determined using ELISA and the Caraway starch-iodine technique. SLC-90 questionnaire was used to determine the psychological profiles. RESULTS: The difference between mean of salivary cortisol levels in patients with BMS and in healthy subjects was not significant (4...
January 23, 2017: Special Care in Dentistry
https://www.readbyqxmd.com/read/28057813/neuropathic-pain-in-patients-with-burning-mouth-syndrome-evaluated-using-paindetect
#9
Pia Lopez-Jornet, Diana Molino-Pagan, Paco Parra-Perez, Sara Valenzuela
OBJECTIVE : This study set out to identify the neuropathic component of pain experienced by burning mouth syndrome (BMS) patients evaluated using painDETECT, a diagnostic tool that could easily be introduced into clinical practice. MATERIALS AND METHODS : This study included 64 patients (33 BMS and 31 suffering nociceptive pain). Each completed the painDETECT neuropathic pain questionnaire, the Hospital Anxiety and Depression Scale, and pain intensity was also measured using a visual analogue scale (VAS)...
January 4, 2017: Pain Medicine: the Official Journal of the American Academy of Pain Medicine
https://www.readbyqxmd.com/read/28029722/taste-function-assessed-by-electrogustometry-in-burning-mouth-syndrome-a-case-control-study
#10
Adeline Braud, Vianney Descroix, Marie-Noëlle Ungeheuer, Catherine Rougeot, Yves Boucher
OBJECTIVE: Idiopathic Burning mouth syndrome (iBMS) is characterized by oral persistent pain without any clinical or biological abnormality. The aim of the present study was to evaluate taste function in iBMS subjects and healthy controls. MATERIAL AND METHODS: Electrogustometric thresholds (EGMt) were recorded in 21 iBMS patients and 21 paired matched controls at nine loci of the tongue assessing fungiform and foliate gustatory papillae function. Comparison of EGMt was performed using the non-parametric Wilcoxon signed-rank test...
December 28, 2016: Oral Diseases
https://www.readbyqxmd.com/read/28025430/the-relationship-between-the-clinical-features-of-idiopathic-burning-mouth-syndrome-and-self-perceived-quality-of-life
#11
Adeline Braud, Yves Boucher
In this descriptive study, we investigated the relationship between the clinical characteristics of idiopathic burning mouth syndrome (iBMS) and the quality of life. Eighteen iBMS patients were interviewed about their experience with pain, oral-associated complaints, cognitive status, and self-perceived quality of life using the French versions of the Hospital Anxiety and Depression Scale (HADS) and the Global Oral Health Assessment Index (GOHAI). The Spearman coefficient was used to analyze correlations. The level of significance was fixed at P < 0...
2016: Journal of Oral Science
https://www.readbyqxmd.com/read/28013436/opiorphin-in-burning-mouth-syndrome-patients-a-case-control-study
#12
Ivan Salarić, Maja Sabalić, Ivan Alajbeg
OBJECTIVES: Opiorphin is a pentapeptide isolated from human saliva that suppresses pain from chemically induced inflammation and acute physical pain. Burning mouth syndrome (BMS) is a chronic condition of a burning sensation in the mouth, where no underlying dental or medical cause can be identified. We aimed to measure the level of opiorphin in whole unstimulated (UWS) and stimulated (SWS) saliva of patients with BMS. MATERIALS AND METHODS: Originally developed and validated LC-MS/MS method was used for opiorphin quantification...
December 24, 2016: Clinical Oral Investigations
https://www.readbyqxmd.com/read/28007005/analgesic-effect-of-topical-oral-capsaicin-gel-in-burning-mouth-syndrome
#13
Mette Rose Jørgensen, Anne Marie Lynge Pedersen
OBJECTIVE: To investigate the effectiveness of repeated topical application of oral capsaicin gel in two different concentrations for relief of burning/stinging sensations in patients with burning mouth syndrome (BMS). MATERIAL AND METHODS: This randomized double-blind cross-over study included 22 female patients with BMS. The patients were randomized for topical application of either 0.01% or 0.025% oral capsaicin gel on the dorsal part of tongue three times daily for 14 days, followed by 14 days wash-out period, and finally treatment with the other concentration of oral gel three times daily for 14 days...
March 2017: Acta Odontologica Scandinavica
https://www.readbyqxmd.com/read/27919663/efficacy-of-low-level-laser-therapy-in-the-treatment-of-burning-mouth-syndrome-a-systematic-review
#14
REVIEW
Sadeq Ali Al-Maweri, Fawad Javed, Butchibabu Kalakonda, Nader A AlAizari, Walid Al-Soneidar, Ameen Al-Akwa
BACKGROUND: Burning mouth syndrome (BMS) is a chronic pain condition with indefinite cure, predominantly affecting post-menopausal women. The aim of this study was to systematically review the efficacy of low level laser therapy in the treatment of burning mouth syndrome (BMS). METHODS: PubMed, Embase and Scopus were searched from date of inception till and including October 2016 using various combinations of the following keywords: burning mouth syndrome, BMS, stomatodynia, laser therapy, laser treatment and phototherapy...
December 2, 2016: Photodiagnosis and Photodynamic Therapy
https://www.readbyqxmd.com/read/27893167/effects-of-low-level-laser-therapy-on-burning-mouth-syndrome
#15
S Valenzuela, P Lopez-Jornet
To investigate low-level laser therapy (LLLT) applied to treat burning mouth syndrome (BMS). This prospective, comparative, partially blinded, single-centre, clinical trial of GaAlAs Laser, with 815 nm wavelength, included 44 BMS patients divided randomly into three groups: Group I (n = 16): GaAlAs laser 815 nm wavelength, 1 W output power, continuous emissions, 4 s, 4 J and fluence rate 133·3 J cm(-2) ; Group II (n = 16): GaAlAs infrared laser, 815 nm wavelength, 1 W output power, continuous emissions, 6 s, 6 J and fluence rate 200 J cm(-2) ; Group III (n = 12) placebo group, sham laser...
February 2017: Journal of Oral Rehabilitation
https://www.readbyqxmd.com/read/27871766/burning-mouth-syndrome-and-associated-factors-a-case-control-retrospective-study
#16
Eduardo Chimenos-Küstner, Fiorella de Luca-Monasterios, Mayra Schemel-Suárez, María E Rodríguez de Rivera-Campillo, Alejandro M Pérez-Pérez, José López-López
BACKGROUND AND OBJECTIVE: Burning mouth syndrome (BMS) can be defined as burning pain or dysesthesia on the tongue and/or other sites of the oral mucosa without a causative identifiable lesion. The discomfort is usually of daily recurrence, with a higher incidence among people aged 50 to 60 years, affecting mostly the female sex and diminishing their quality of life. The aim of this study was to evaluate the association between several pathogenic factors and burning mouth syndrome. PATIENTS AND METHODS: 736 medical records of patients diagnosed of burning mouth syndrome and 132 medical records for the control group were studied retrospectively...
February 23, 2017: Medicina Clínica
https://www.readbyqxmd.com/read/27866178/low-level-laser-therapy-a-review-of-its-applications-in-the-management-of-oral-mucosal-disorders
#17
Juliana Cassol Spanemberg, Maria Antonia Zancanaro Figueiredo, Karen Cherubini, Fernanda Gonçalves Salum
Due to its analgesic, anti-inflammatory, and biostimulating effects, low-level laser therapy (LLLT) has been widely used for oral disorders, such as oral lichen planus (OLP), xerostomia, recurrent aphthous stomatitis (RAS), herpes labialis, burning mouth syndrome (BMS), and oral mucositis (OM). The research team for the present study has reviewed the literature on the subject, with an emphasis on the applicability of LLLT in general and of its various clinical protocols for the management of those oral disorders...
November 2016: Alternative Therapies in Health and Medicine
https://www.readbyqxmd.com/read/27862315/evaluation-of-salivary-oxidate-stress-biomarkers-nitric-oxide-and-c-reactive-protein-in-patients-with-oral-lichen-planus-and-burning-mouth-syndrome
#18
Asta Tvarijonaviciute, Cristina Aznar-Cayuela, Camila P Rubio, José J Ceron, Pia López-Jornet
OBJECTIVES: The aim of this study was to evaluate oxidative stress factors and C-reactive protein in the saliva of patients with oral lichen planus (OLP) and burning mouth syndrome (BMS). METHODS: This consecutive, cross-sectional study included 20 patients with OLP, 19 with burning mouth syndrome (BMS), and 31 control subjects. The oral cavity of each patient was examined and patients responded to a quality of life questionnaire (OHIP-14) and the xerostomia inventory...
November 8, 2016: Journal of Oral Pathology & Medicine
https://www.readbyqxmd.com/read/27855478/interventions-for-treating-burning-mouth-syndrome
#19
REVIEW
Roddy McMillan, Heli Forssell, John Ag Buchanan, Anne-Marie Glenny, Jo C Weldon, Joanna M Zakrzewska
BACKGROUND: Burning mouth syndrome (BMS) is a term used for oral mucosal pain (burning pain or discomfort in the tongue, lips or entire oral cavity) without identifiable cause. General population prevalence varies from 0.1% to 3.9%. Many BMS patients indicate anxiety, depression, personality disorders and impaired quality of life (QoL). This review updates the previous versions published in 2000 and 2005. OBJECTIVES: To determine the effectiveness and safety of any intervention versus placebo for symptom relief and changes in QoL, taste, and feeling of dryness in people with BMS...
18, 2016: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/27834029/opiorphin-levels-in-fluids-of-burning-mouth-syndrome-patients-a-case-control-study
#20
Yves Boucher, Adeline Braud, Evelyne Dufour, Scarlette Agbo-Godeau, Vanessa Baaroun, Vianney Descroix, Marie-Thérèse Guinnepain, Marie-Noëlle Ungeheuer, Catherine Ottone, Catherine Rougeot
OBJECTIVES: Idiopathic Burning mouth syndrome (iBMS) is a poorly understood affection characterized by persistent pain in the oral cavity without any clinical or biological abnormality. Opiorphin is a natural inhibitor of enkephalin-inactivating ectopeptidases, mainly produced by salivary glands, that has demonstrated analgesic properties. The objective of the present case-control study was to test the hypothesis of a decrease in opiorphin levels in iBMS patients. MATERIALS AND METHODS: Twenty-one iBMS patients and 21 matched controls subjects were included between 2011 and 2013...
November 10, 2016: Clinical Oral Investigations
keyword
keyword
27427
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"